The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
0809009 Informal Interpretation
Negotiated Data Solutions LLC., In the Matter of
The Commission charged that Negotiated Data Solutions LLC (N-Data) violated Section 5 of the FTC Act by engaging in unfair methods of competition. N-Data acquired patent rights originally held by National Semiconductor Corp. which were included in an IEEE industry standard for autonegotiation technology, which allows Ethernet devices made by different manufacturers to work together. Ethernet is a computer networking standard that is used in nearly every computer sold in the U.S. N-Data reneged on National Semiconductor’s commitment to charge a one-time royalty of $1000 to manufacturers or sellers of products using the IEEE standard, and demanded higher royalties from users. In a consent agreement resolving the charges, N-Data must stop enforcing the patents at issue unless N-Data has first offered a license under the original terms.
0809010 Informal Interpretation
20081775: OCM Principal Opportunities Fund IV, L.P.; Nevada Chemicals, Inc.
20081770: Prudential Financial Inc.; MC Insurance Agency Services Holdings, LLC
20081769: Prudential Financial Inc.; Nationwide Mutual Insurance Company
Prepared Statement of the Federal Trade Commission On Marketing Food To Children and Adolescents: A Review of Industry Expenditures, Activities, and Self-Regulation
Financial Advisors & Associates Inc. also d/b/a Freedom Financial , et al.
20081774: DCP Midstream Partners, LP; Ganesh Energy, LLC
20081766: J.H. Whitney VI, L.P.; George and Julianne Argyros
20081745: Audax Private Equity Fund III, L.P.; Mobilex Acquisition Group, LLC
20081727: Audax Private Equity Fund III, L.P.; Andrews Holding, LLC
0809008 Informal Interpretation
Carlyle Partners IV, L.P., et al., In the Matter of
The Commission challenged the proposed acquisition by Carlyle Partners IV, L.P. of INEOS Group Ltd., alleging that the deal would be anticompetitive in the highly concentrated Midwestern market for sodium silicate. Sodium silicates are used in detergents and other products, and are important chemicals used by the pulp and paper industry. The acquisition would have joined market leader PQ Corporation, which is owned by Carlyle, with INEOS, the third-largest sodium silicate provider. Under the Commission’s order, Carlyle must divest PQ’s sodium silicate plant in Utica, Illinois, and all associated intellectual property required to operate the plant to Oak Hill Company within five days of consummating the transaction.
Sun Pharmaceutical Industries Ltd., In the Matter of (Taro Pharmaceuticals)
The Commission charged that Sun Pharmaceutical Industries Ltd’s proposed acquisition of Taro Pharmaceuticals Industries, Ltd would substantially reduce competition, likely resulting in higher prices for three distinct generic formulations of the anticonvulsant drug carbamazepine, used widely as an antiepileptic and to prevent and control seizures. The proposed deal would have reduced the number of drug suppliers to a level where the number of competitors has a direct and substantial impact on prices. In order to remedy these concerns, Sun agreed to divest all of its rights and assets needed to develop three generic forms of carbamazepine: 1) immediate-release tablets; 2) chewable tablets; and 3) extended-release tablets.